Shenzhen YHLO Biotech Co., Ltd.

Equities

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
22.89 CNY +1.78% Intraday chart for Shenzhen YHLO Biotech Co., Ltd. -0.39% +0.09%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
YHLO Biotech Secures US FDA Clearance for Two In-Vitro Diagnostics Products MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shenzhen YHLO Biotech Co., Ltd.(XSSC:688575) added to S&P Global BMI Index CI
YHLO Biotech Registers Reagent For Detecting Heart Failure MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2023. CI
YHLO Biotech Unit Gets Certification for Two Medical Devices MT
YHLO Biotech Unit Registers New Medical Device MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
YHLO Biotech Gets Registration Certificate for Automatic Biochemical Analyzer MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
YHLO Biotech Gets Registration Certificate for Anti-Desmoglein 3 Antibody Detection Kit MT
YHLO Biotech's COVID-19 Antigen Kit Added to WHO's Emergency Use List MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Longlight announced that it has received $1.380000 million in funding from Shenzhen YHLO Biotech Co., Ltd., Yanghe Capital Holding Group Limited and other investors. CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Shenzhen YHLO Biotech Co., Ltd.(SHSE:688575) added to Shanghai Stock Exchange A Share Index CI
Shenzhen YHLO Biotech Co., Ltd.(SHSE:688575) added to Shanghai Stock Exchange Composite Index CI
Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2022. CI
Yunkang Braves Market Turbulence with Launch of $139 Million Hong Kong IPO MT
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
YHLO Biotech Bags Nearly $53 Million Supply Deal With Japan’s JSR; Shares Fall 3% MT
Chart Shenzhen YHLO Biotech Co., Ltd.
More charts
Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
22.89 CNY
Average target price
28.67 CNY
Spread / Average Target
+25.24%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688575 Stock
  4. News Shenzhen YHLO Biotech Co., Ltd.
  5. YHLO Biotech’s COVID-19 Test Kits Wins Clearance in Japan; Shares Rally 14%